Jump directly to
  • Jump directly to the main content
  • Jump directly to the search
Bayer logoBayer logo
Bayer Half-Year Financial Report Q2 2026
  • Wechsele die Sprache zu: Deutsch Deutsch de
Main menu
  • Interim Group Management Report
    • Interim Group Management Report
    • Key Events
    • Sales, Earnings and Financial Position
      • Sales, Earnings and Financial Position
      • Earnings Performance
      • Business Development by Division
        • Business Development by Division
        • Crop Science
        • Pharmaceuticals
        • Consumer Health
      • Financial Position
    • Research, Development, Innovation
      • Research, Development, Innovation
      • Crop Science
      • Pharmaceuticals
      • Consumer Health
      • Leaps by Bayer
    • Report on Future Perspectives and on Opportunities and Risks
      • Report on Future Perspectives and on Opportunities and Risks
      • Future Perspectives
      • Opportunities and Risks
  • Condensed Consolidated Interim Financial Statements
    • Condensed Consolidated Interim Financial Statements
    • Condensed Consolidated Income Statements
    • Condensed Consolidated Statements of Comprehensive Income
    • Condensed Consolidated Statements of Financial Position
    • Condensed Consolidated Statements of Cash Flows
    • Condensed Consolidated Statements of Changes in Equity
    • Notes to the Condensed Consolidated Interim Financial Statements
      • Notes to the Condensed Consolidated Interim Financial Statements
      • Explanatory Notes
      • Contingent Liabilities
      • Legal Risks
      • Notes to the Statements of Cash Flows
      • Related Parties
      • Other Information
    • Events After the End of the Reporting Period
  • Additional information
    • Additional information
    • Responsibility Statement
    • Report on Review of Interim Financial Information
    • Financial Calendar
    • Reporting Principles
Downloads
bayer.com
  • Home
  • Interim Group Management Report
  • Sales, Earnings and Financial Position

Overview of Sales, Earnings and Financial Position1

1 For definition of alternative performance measures see Annual Report 2025, A 2.3 “Alternative Performance Measures Used by the Bayer Group.”

previous page: Key Events next page: Earnings Performance
  • Key Events
  • Earnings Performance
  • Bayer logo Health for all, Hunger for none Health for all, Hunger for none

    Follow us for Updates and Insights

    • LinkedIn
    • YouTube
    • Instagram
    • X
    • Facebook

    The Half-Year Financial Report for the second quarter of 2026 can be downloaded here.
    Bayer’s Annual Report for 2025 is available for download here.

    • Corporate Website
    • Investor Relations
    • Imprint
    • Privacy Policy

    Copyright © Bayer AG | Published: August 4, 2026

    Change report

    Annual Reports

    • 2025 Aerial view of the Bayer AG corporate headquarters in Leverkusen.

    Quarterly Statements

    • Q1 2026 Homepage section featuring the colorful Bayer AG logo.
    • Q2 2026 Bayer logo displayed on a field in shades of green and gold. currently viewing
    View older reports